Green Thumb Industries Inc.
Green Thumb Industries Inc.
Your view on GTBIF
Overview
What the company does, where it operates, and who runs it.
About Green Thumb Industries Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Benjamin Kovler
- Headquarters
- 325 West Huron Street, Chicago, IL, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Benjamin Kovler
- Headquarters
- 325 West Huron Street, Chicago, IL, US
Green Thumb Industries Inc. engages in manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States.
It offers cannabis flower; and processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, and other cannabis-related products under the Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of April 11, 2022, it owned and operated 77 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Green Thumb Industries Inc., and the rating behind it. GTBIF last traded at $6.60, 13.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Green Thumb Industries Inc.. Starting points for Green Thumb Industries Inc.: P/E 13.4, EPS $0.58, beta 0.92 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Green Thumb Industries Inc.. Green Thumb Industries Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Green Thumb Industries Inc.. Trailing twelve-month EPS for Green Thumb Industries Inc. stands at $0.58. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Green Thumb Industries Inc.. Green Thumb Industries Inc. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Green Thumb Industries Inc. valued side by side against its closest peers. Green Thumb Industries Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Green Thumb Industries Inc., and how their positions are changing. At a $1.53B market value, institutional positions materially move Green Thumb Industries Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Green Thumb Industries Inc. executives and directors. Shares of Green Thumb Industries Inc. have traded between $4.63 and $10.43 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Green Thumb Industries Inc.. Green Thumb Industries Inc. is a $1.53B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Green Thumb Industries Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Green Thumb Industries Inc.. Coverage tracks Green Thumb Industries Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.